COVID-19 ThromboprophylaXIs Study of Novel FXIa Inhibitor Frunexian (EP-7041) in ICU Patients
Clinical trial NCT05040776 · WITHDRAWN
Trial details
- NCT number
- NCT05040776
- Sponsor
- eXIthera Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2024-05-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.